Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) and Risk of Hepatocellular Carcinoma (HCC) in Chronic Hepatitis B (CHB)

Authors

Institutions

Publication Details

Journal
Journal of Gastroenterology and Hepatology
Published
2026-04-16
DOI
https://doi.org/10.1111/jgh.70398
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) and Risk of Hepatocellular Carcinoma (HCC) in Chronic Hepatitis B (CHB)

Fauzia Hollnagel, Dawd S. Siraj
Journal of Gastroenterology and Hepatology
Hepatitis B Virus Studies
article

Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) and Risk of Hepatocellular Carcinoma (HCC) in Chronic Hepatitis B (CHB)

Fauzia Hollnagel, Dawd S. Siraj
article en

Abstract

No abstract available for this paper.
Journal of Gastroenterology and Hepatology
University of Wisconsin–Madison (US)
Good health and well-being
Openalex Percentile: Top 10%
Hepatitis B Virus Studies
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.